Zocor



Combined with:

Yaz

Indications and Reactions:

Role Indications Reactions
Primary
Hypercholesterolaemia 17.8%
Blood Cholesterol Increased 17.1%
Hypertension 13.7%
Hyperlipidaemia 10.3%
Acute Coronary Syndrome 5.1%
Myocardial Ischaemia 4.3%
Diabetes Mellitus 4.1%
Blood Cholesterol 3.8%
Coronary Artery Disease 3.6%
Type 2 Diabetes Mellitus 2.6%
Cardiovascular Event Prophylaxis 2.2%
Dyslipidaemia 2.1%
Prophylaxis 2.1%
Atrial Fibrillation 1.8%
Product Used For Unknown Indication 1.7%
Depression 1.7%
Angina Pectoris 1.7%
Myocardial Infarction 1.6%
Hypothyroidism 1.5%
Pain 1.1%
Rhabdomyolysis 37.8%
Myalgia 14.9%
Pain In Extremity 6.4%
Myopathy 3.6%
Muscle Spasms 3.5%
Myositis 3.1%
Muscular Weakness 3.0%
Pain 3.0%
Vomiting 3.0%
Myocardial Infarction 2.7%
Renal Failure Acute 2.7%
Weight Decreased 2.5%
Drug Interaction 2.3%
Wrong Technique In Drug Usage Process 2.0%
Renal Failure 1.9%
Blood Creatine Phosphokinase Increased 1.6%
Tendon Rupture 1.6%
Drug Hypersensitivity 1.5%
Cerebrovascular Accident 1.4%
Drug Ineffective 1.3%
Secondary
Blood Cholesterol Increased 17.5%
Hypercholesterolaemia 13.2%
Product Used For Unknown Indication 12.5%
Hypertension 11.2%
Drug Use For Unknown Indication 9.9%
Hyperlipidaemia 6.7%
Coronary Artery Disease 3.5%
Myocardial Ischaemia 3.5%
Diabetes Mellitus 3.4%
Type 2 Diabetes Mellitus 3.1%
Blood Cholesterol 2.7%
Depression 1.9%
Cardiac Disorder 1.9%
Pain 1.5%
Atrial Fibrillation 1.4%
Cardiovascular Event Prophylaxis 1.3%
Myocardial Infarction 1.3%
Prophylaxis 1.2%
Blood Triglycerides Increased 1.2%
Ill-defined Disorder 1.2%
Rhabdomyolysis 22.4%
Myalgia 12.8%
Drug Hypersensitivity 7.1%
Pain In Extremity 6.9%
Wrong Technique In Drug Usage Process 5.9%
Vomiting 5.4%
Weight Decreased 4.5%
Pain 4.0%
Muscle Spasms 3.8%
Weight Increased 3.2%
Myopathy 3.1%
Pulmonary Embolism 3.0%
Myocardial Infarction 2.7%
Muscular Weakness 2.6%
Myositis 2.5%
Renal Failure Acute 2.4%
Pancreatitis 2.3%
Blood Creatine Phosphokinase Increased 2.0%
Nausea 1.9%
Overdose 1.8%
Concomitant
Product Used For Unknown Indication 23.6%
Drug Use For Unknown Indication 15.5%
Hypertension 10.7%
Blood Cholesterol Increased 6.0%
Diabetes Mellitus 5.5%
Depression 4.3%
Pain 4.3%
Osteoporosis 3.3%
Rheumatoid Arthritis 3.2%
Type 2 Diabetes Mellitus 3.0%
Gastrooesophageal Reflux Disease 2.8%
Atrial Fibrillation 2.6%
Anxiety 2.1%
Blood Cholesterol 2.0%
Arthritis 2.0%
Cardiac Disorder 2.0%
Chronic Obstructive Pulmonary Disease 1.9%
Prophylaxis 1.8%
Blood Pressure 1.8%
Multiple Myeloma 1.6%
Weight Decreased 11.2%
Myocardial Infarction 10.9%
Vomiting 10.7%
Weight Increased 8.2%
Nausea 6.0%
Drug Ineffective 5.2%
Pain 4.8%
Type 2 Diabetes Mellitus 4.3%
Vision Blurred 4.3%
Death 4.1%
Urinary Tract Infection 3.7%
Renal Failure 3.2%
Dyspnoea 3.2%
Flushing 3.1%
Transient Ischaemic Attack 2.9%
Tremor 2.9%
Pneumonia 2.9%
Somnolence 2.9%
Cerebrovascular Accident 2.8%
Syncope 2.7%
Interacting
Drug Use For Unknown Indication 19.7%
Product Used For Unknown Indication 15.6%
Hypertension 8.2%
Hiv Infection 6.6%
Hyperlipidaemia 6.6%
Blood Cholesterol Increased 4.9%
Blood Cholesterol 4.1%
Diabetes Mellitus 4.1%
Hypercholesterolaemia 4.1%
Asthma 3.3%
Dyslipidaemia 3.3%
Blood Cholesterol Abnormal 2.5%
Depression 2.5%
Heart Transplant 2.5%
Hypersensitivity 2.5%
Lipids 2.5%
Prophylaxis 2.5%
Abstains From Alcohol 1.6%
Arteriosclerosis 1.6%
Atrioventricular Block 1.6%
Rhabdomyolysis 29.1%
Drug Interaction 12.7%
Jaundice 5.5%
Myalgia 5.5%
Drug Ineffective 3.6%
Feeling Abnormal 3.6%
Haematoma 3.6%
International Normalised Ratio Increased 3.6%
Thrombophlebitis Superficial 3.6%
Tricuspid Valve Incompetence 3.6%
Upper Limb Fracture 3.6%
Visual Disturbance 3.6%
Vitamin B1 Increased 3.6%
Vomiting 3.6%
Aspartate Aminotransferase Increased 1.8%
Asthenia 1.8%
Back Pain 1.8%
Blood Creatine Phosphokinase Increased 1.8%
Discomfort 1.8%
Drug Dose Omission 1.8%